Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer.

Journal of Korean medical science - 1 Feb 2011

Ha Yun-Sok, Yan Chunri, Jeong Pildu, Kim Won Tae, Yun Seok-Joong, Kim Isaac Yi, Moon Sung-Kwon, Kim Wun-Jae

Abstract excerpt

Tissue genotyping is more useful approach than using blood genomic DNA, which can reflect the effects of the somatic mutations in cancer. Although polymorphisms in glutathione S-transferase (GST) have been associated with the risk of bladder cancer (BC) development, few reports provide information about the prognosis of BC. We investigated glutathione S-transferase mu (GSTM1) and glutathione S-transferase theta...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Glutathione Transferase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isoenzymes

Share to Kaplan-Meier Estimate

Share to Prognosis

Share to Proportional Hazards Models

Share to Recurrence

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 21286014
DOI: 10.3346/jkms.2011.26.2.231
PMCID: PMC3031007

Genes

GSTM1
GSTT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer.PMID 21286014Read ↗

GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer.Semantic proximity Read ↗

GSTT1: a marker of the aggressiveness of bladder cancer.Semantic proximity Read ↗

Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.Semantic proximity Read ↗

Genetic Variations in Glutathione Pathway Genes Predict Cancer Recurrence in Patients Treated with Transurethral Resection and Bacillus Calmette-Guerin Instillation for Non-muscle Invasive Bladder Cancer.Semantic proximity Read ↗

Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction.Semantic proximity Read ↗

The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer.Semantic proximity Read ↗

Impact of Occupational Exposures and Genetic Polymorphisms on Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer.Semantic proximity Read ↗

The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non-muscle invasive bladder cancer.Semantic proximity Read ↗

Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer.Semantic proximity Read ↗

The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association study.Semantic proximity Read ↗

TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.Semantic proximity Read ↗

Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.